1. Academic Validation
  2. MicroRNA-301a (miR-301a) is induced in hepatocellular carcinoma (HCC) and down- regulates the expression of interferon regulatory factor-1

MicroRNA-301a (miR-301a) is induced in hepatocellular carcinoma (HCC) and down- regulates the expression of interferon regulatory factor-1

  • Biochem Biophys Res Commun. 2020 Apr 2;524(2):273-279. doi: 10.1016/j.bbrc.2020.01.034.
Kun Dong 1 Qiang Du 2 Xiao Cui 2 Peiqi Wan 2 Christof Kaltenmeier 2 Jing Luo 2 Bing Yan 2 Yihe Yan 2 David A Geller 3
Affiliations

Affiliations

  • 1 Department of Pediatric Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530021, China.
  • 2 Department of Surgery, University of Pittsburgh, Pittsburgh, PA, 15213, USA.
  • 3 Department of Surgery, University of Pittsburgh, Pittsburgh, PA, 15213, USA. Electronic address: [email protected].
Abstract

Hepatocellular carcinoma (HCC) tumors evade death in part by downregulating expression of the tumor suppressor gene Interferon regulatory factor-1 (IRF-1). However, the molecular mechanisms accounting for IRF-1 suppression in HCC have not been well described. In this study, we identified a novel microRNA-301a (miR-301a) binding site in the 3'-untranslated region (3'- UTR) of the human IRF-1 gene and hypothesized a functional role for miR-301a in regulating HCC growth. We show that miR-301a is markedly upregulated in primary HCC tumors and HCC cell lines, while IRF-1 is down-regulated in a post-transcriptional manner. MiR-301a regulates basal and inducible IRF-1 expression in HCC cells with an inverse relationship between miR-301a and IRF-1 expression in HCC cells. Chronic hypoxia induces miR-301a in HCC in vitro and decreases IRF-1 expression. Finally, miR-301a inhibition increases Apoptosis and decreases HCC cell proliferation. These findings suggest that targeting of IRF-1 by miR-301a contributes to the molecular basis for IRF-1 downregulation in HCC and provides new insight into the regulation of HCC by miRNAs.

Keywords

Apoptosis; HCC; Hypoxia; IRF-1; Proliferation; miR-301a.

Figures
Products